Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04730349
Title A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer (PIVOT IO 020)
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

neuroblastoma

acute lymphoblastic leukemia

non-Hodgkin lymphoma

Advanced Solid Tumor

central nervous system cancer

Therapies

Nivolumab + NKTR-214

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.